Dolphin Life Science (India) LLP
About Dolphin Life Science (India) LLP
Data last updated:
Dolphin Life Science (India) LLP is a limited liability partnership (LLP) based in Surat, Gujarat, India. It operates in the medical consumables and supplies segment of the healthcare sector. It was incorporated on 07 March 2016 and has been in existence for over 10 years.
The LLP is registered with the Registrar of Companies (ROC), Ahmedabad, under LLPIN AAF-8714.
The LLP has a total obligation of contribution of ₹3 Cr. It is led by designated partners Mukeshkumar Babulal Chovatiya and Ruchit Bhupatbhai Ramolia.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Surat, Gujarat.
As per the financials filed for FY 2023, the LLP reported a revenue of ₹5.37 Cr, a decline of 25% compared to the previous year. Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 162% over five years.
As per MCA filings, the LLP has open charges of ₹16.95 Cr and satisfied charges of ₹35 Cr on record.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressShop G – 15 Raghuvir Business Empire Nr Aai Mata Chowk Puna Kumbharia Road, Magob, Surat, Gujarat, India – 395010
- IndustryHealthcare, Medical Consumables & Supplies
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Dolphin Life Science (India) LLP FY 2025 filings available
Dolphin Life Science (India) LLP reported revenue of ₹5.37 Cr (down 25% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR) of Dolphin Life Science (India) LLP
Revenue fell 25% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 162%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Dolphin Life Science (India) LLP
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Income | •••• | •••• | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• | •••• | •••• |
| Profit After Tax | •••• | •••• | •••• | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• | •••• | •••• |
| Assets and Liabilities | |||||
| Partners' Contribution | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Dolphin Life Science (India) LLP
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Dolphin Life Science (India) are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Dolphin Life Science (India) LLP
Dolphin Life Science (India) LLP is compared with the companies closest to it by revenue in the Healthcare industry (Medical Consumables). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Janis Care Private Limited | ₹5.55 Cr (FY 2025) | •••• | •••• | 101.0% | •••• | Gujarat, India |
| Madhuson Overseas Private Limited | ₹5.51 Cr (FY 2025) | •••• | •••• | -3.0% | •••• | New Delhi, Delhi, India |
| Labstar Multiplast Private Limited | ₹5.41 Cr (FY 2025) | •••• | •••• | 53.0% | •••• | Mumbai, Maharashtra, India |
| Tiger Surgical Disposable Private Limited | ₹5.38 Cr (FY 2024) | •••• | •••• | -46.0% | •••• | Ahmedabad, Gujarat, India |
| GR Polyglov Private Limited | ₹5.37 Cr (FY 2025) | •••• | •••• | 27.0% | •••• | Mumbai, Maharashtra, India |
| Dolphin Life Science (India) LLP this company | ₹5.37 Cr (FY 2023) | •••• | •••• | -25.0% | •••• | Surat, Gujarat, India |
| Solfir Industries Private Limited | ₹5.34 Cr (FY 2025) | •••• | •••• | 123.0% | •••• | Taloja, Maharashtra, India |
| Sri Vishnu Disposables Private Limited | ₹5.33 Cr (FY 2025) | •••• | •••• | -9.0% | •••• | Sriperumbathur, Tamil Nadu, India |
| Abhay Healthtech Private Limited | ₹5.3 Cr (FY 2025) | •••• | •••• | 4687.0% | •••• | Gurgaon, Haryana, India |
| Lifeshield Healthcare Private Limited | ₹5.29 Cr (FY 2024) | •••• | •••• | 218.0% | •••• | Delhi, India |
| Krishna Technologist Private Limited | ₹5.29 Cr (FY 2025) | •••• | •••• | -5.0% | •••• | Ghaziabad, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Dolphin Life Science (India) by revenue in the Healthcare industry (Medical Consumables), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Designated Partners of Dolphin Life Science (India) LLP
Dolphin Life Science (India) has 2 current designated partners and 1 former designated partner. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mukeshkumar Babulal Chovatiya Also directs: Vaidik Ayurved Research Private Limited, Dolphin Scientific (India) Private Limited, Dolphin Embro India Private Limited and 1 more | Designated Partner | 07 Mar 2016 | 10 Years 7 Months | Current |
| Ruchit Bhupatbhai Ramolia | Designated Partner | 10 Jul 2022 | 4 Years 3 Months | Current |
Ownership and Shareholding of Dolphin Life Science (India) LLP
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Dolphin Life Science (India) LLP
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Aug 2024 | The Karur Vysya Bank Limited | ₹3.5 Cr | Open |
| 28 Jun 2024 | Hdfc Bank Limited | ₹5.27 Lakh | Open |
| 07 Apr 2023 | The Karur Vysya Bank Limited | ₹13.4 Cr | Open |
| 20 Nov 2018 | The Varachha Co Op Bank Limited | ₹3.5 Cr | Satisfied |
| 04 Sep 2018 | The Varachha Co Op Bank Limited | ₹9 Cr | Satisfied |
Total charge records: 9 View all charges
Employees and EPFO Compliance at Dolphin Life Science (India) LLP
Employment history and EPFO contributions of people linked to Dolphin Life Science (India).
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Dolphin Life Science (India) LLP
Dolphin Life Science (India) LLP has 3 designated partner changes on record since 2016: 2 appointments and 1 cessation. The latest: Ruchit Bhupatbhai Ramolia was appointed as Designated Partner on 10 Jul 2022.
10 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Dolphin Life Science (India) LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Dolphin Life Science (India) LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Dolphin Life Science (India) LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Dolphin Life Science (India) LLP
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Dolphin Life Science (India) LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dolphin Life Science (India) LLP
Dolphin Life Science (India) is an active limited liability partnership based in Surat, Gujarat, India. The LLP works in medical consumables and supplies, within the healthcare industry. It was incorporated on 07 March 2016 (10+ years old) and is registered under LLPIN AAF-8714.
Dolphin Life Science (India) reported revenue of ₹5.37 Cr for FY 2023 (down 25% YoY).
Dolphin Life Science (India) has 2 current designated partners:
- Mukeshkumar Babulal Chovatiya - Designated Partner
- Ruchit Bhupatbhai Ramolia - Designated Partner
The compounded annual growth rate (CAGR) of the revenue of Dolphin Life Science (India) is 9% over three years and 162% over five years. In the latest year (FY 2023) revenue fell 25%. CAGR is the steady yearly rate that links the first and the last year.
The LLPIN (Limited Liability Partnership Identification Number) of Dolphin Life Science (India) is AAF-8714. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Dolphin Life Science (India) was incorporated on 07 March 2016, making it 10+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Dolphin Life Science (India) by revenue are Janis Care Private Limited, Madhuson Overseas Private Limited, Labstar Multiplast Private Limited, Tiger Surgical Disposable Private Limited, GR Polyglov Private Limited and 5 more, all in the Healthcare industry (Medical Consumables).
Ruchit Bhupatbhai Ramolia was appointed as Designated Partner on 10 Jul 2022. Sanjay Babulal Chovatia ceased to be Designated Partner on 10 Jul 2022. Mukeshkumar Babulal Chovatiya was appointed as Designated Partner on 07 Mar 2016.
The registered office of Dolphin Life Science (India) is at Shop G – 15 Raghuvir Business Empire Nr Aai Mata Chowk Puna Kumbharia Road, Magob, Surat, Gujarat, India – 395010.
The total obligation of contribution is ₹3 Cr.
Dolphin Life Science (India) operates in the healthcare industry, in the medical consumables and supplies segment.